US 12,128,032 B2
Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultry
Anja Regina Heckeroth, Stadecken-Elsheim (DE); Hartmut Zoller, Hochheim (DE); Annie Flochlay-Sigognault, Angers (FR); and Bruno Huyghe, St Martin du Fouilloux (FR)
Assigned to Intervet Inc., New (JE)
Filed by Intervet Inc., Madison, NJ (US)
Filed on Mar. 8, 2022, as Appl. No. 17/653,950.
Application 17/653,950 is a continuation of application No. 16/849,487, filed on Apr. 15, 2020.
Application 16/849,487 is a continuation of application No. 16/293,024, filed on Mar. 5, 2019, granted, now 10,653,675, issued on May 19, 2020.
Application 16/293,024 is a continuation of application No. 15/105,197, granted, now 10,272,071, issued on Apr. 30, 2019, previously published as PCT/EP2014/078636, filed on Dec. 19, 2014.
Claims priority of application No. 13199007 (EP), filed on Dec. 20, 2013.
Prior Publication US 2022/0193040 A1, Jun. 23, 2022
Int. Cl. A01N 43/80 (2006.01); A01N 43/90 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 31/42 (2006.01); A61K 31/422 (2006.01); A61K 31/437 (2006.01); A61K 47/10 (2017.01); A61K 47/26 (2006.01)
CPC A61K 31/42 (2013.01) [A01N 43/80 (2013.01); A01N 43/90 (2013.01); A61K 9/0053 (2013.01); A61K 9/08 (2013.01); A61K 31/422 (2013.01); A61K 31/437 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01)] 5 Claims
 
1. A pharmaceutical composition comprising an isoxazoline compound or a salt or solvate thereof, and a pharmaceutically acceptable carrier, wherein the isoxazoline compound is fluralaner and the pharmaceutically acceptable carrier comprises diethylene glycol monoethyl ether and a polysorbate.